Research Support

Sydney Catalyst offers support for our members through various channels. If we can help further your research in any way, we're happy to assist.

Sydney Catalyst Mentoring Program

Sydney Catalyst is proud to be running our successful mentorin program for the third year. The program seeks to expand member engagement and collaboration and networking opportunities. Places will be limited and applications will undergo a competitive selection process.

Biostatistics

Sydney Catalyst is pleased to partner with the NHMRC Clinical Trial Centre to offer biostatistics support to members of Sydney Catalyst.

Sydney Catalyst Support for Project Grant Applications

Sydney Catalyst hopes to provide assistance to our members as they prepare for project grant applications.

Creating new and strengthening existing collaborations

Sydney Catalyst has more than 500 members, all of whom have a primary focus in cancer research or treatment, and an incredibly broad range of research interests and expertise in translational research across the full continuum from basic biosciences...

Developing and supporting a strong translational cancer research program

Sydney Catalyst has a small central team with expertise in concept and project development (incl. research design and operations, biostatistics, budget development and management etc.), who in turn have access to a larger group of senior investigators...

Other support?

Sydney Catalyst has created an online presentation for members entitled: 'Writing Successful Grants for Translational Research.'

In addition to the above, there may be other ways that we can offer support to our members in their applications for funding, so please don't hesitate to make contact with us. We'd like to reiterate that our plan is work closely with our member groups, many of which have their own processes for identifying collaborators, concept and project development etc. We're not interested in duplicating effort, just keen to explore news ways that we can support our members and significantly contribute to high quality translational cancer research.